Nuro 🌐
DoomBench currently associates 0 models and 3 evidence assessments with Nuro. Company attribution is separate from each model's version-specific risk score.
- Tracked models
- 0
- Evidence items
- 3
- Toward-doom share
- 0.0%
- Net index pressure
- -0.01
0 comments · 0 votes
Sign in to join the discussion →
No comments yet. Start the discussion.
Models from Nuro
Availability distinguishes public artifacts, proprietary hosted access, internal systems, and profiles whose current source evidence remains inconclusive.
No version-specific model profiles are associated with this company yet.
Latest assessments involving Nuro
Anthropic reports deployed auto mode cuts serious unintended agent harm
Anthropic reported that Claude Code's deployed permission classifier reduced production-level unintended harm in reviewed sessions from 6.3% under manual approval to 2.4%. Separate dated production case studies document sustained use at Nuro, Gusto, and Garner Health, while third-party testing found no successful attacks against three current Claude models in 720 prompt-injection trials.
California grants Nuro its first commercial driverless deployment permit
California issued Nuro the state's first autonomous-vehicle deployment permit, allowing the company to charge for driverless delivery services in San Mateo and Santa Clara counties.
Nuro raises $500 million to scale autonomous delivery
Nuro raised a $500 million Series C round to expand its autonomous road-delivery business after deploying its second-generation R2 vehicle, a purpose-built vehicle with no steering wheel, pedals, or driver compartment.